Skip to main content

Advertisement

Table 2 Number of post-1981 drugs ever launched in Mexico, by cancer site, 1986–2013

From: The impact of pharmaceutical innovation on cancer mortality in Mexico, 2003–2013

ICD_WHO 1986 1989 1992 1995 1998 2001 2004 2007 2010 2013
C00–14 lip, oral cavity and pharynx 0 0 0 1 1 1 2 2 2 2
C15 oesophagus 0 0 0 1 1 2 2 2 2 2
C16 stomach 0 0 0 1 1 2 2 2 2 2
C18–21 colon, rectum and anus 0 0 0 0 1 2 4 5 5 6
C25 pancreas 0 0 0 1 3 3 3 6 6 6
C33–34 lung (incl. trachea and bronchus) 0 0 1 3 5 5 6 9 10 11
C43 melanoma of skin 0 1 1 1 2 3 3 3 3 5
C45 mesothelioma 0 0 0 0 0 0 0 1 1 1
C50 breast 0 1 2 4 7 11 12 13 16 16
C53 cervix uteri 0 0 0 0 0 0 0 1 2 2
C56 ovary 0 0 1 2 3 3 3 4 5 5
C61 prostate 0 3 4 5 6 6 6 6 7 8
C64 kidney 0 0 0 0 1 1 1 4 4 6
C70–72 brain, central nervous system 0 0 0 0 0 1 1 3 3 3
C73 thyroid 0 0 0 0 0 0 0 0 0 0
C81 hodgkin lymphoma 0 0 0 0 0 0 0 0 0 0
C82–85, C96 non-hodgkin lymphoma 0 1 1 1 1 2 2 3 5 5
C88 + C90 multiple myeloma 0 0 0 0 0 1 1 2 4 4
C91–95 leukemia 0 2 3 3 3 5 5 7 8 8
Mean 0.0 0.4 0.7 1.2 1.8 2.5 2.8 3.8 4.5 4.8